A randomized, clinical trial to assess the relative efficacy and tolerability of two doses of etoricoxib versus naproxen in patients with ankylosing spondylitis

BACKGROUND: This study evaluated two doses of etoricoxib (60 and 90 mg) vs. naproxen 1000 mg in subjects with ankylosing spondylitis (AS). METHODS: This was a 2-part, double-blind, active comparator-controlled non-inferiority study in subjects ≥18 years of age with AS. In Part I, subjects were rando...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :BMC Musculoskelet Disord
Главные авторы: Balazcs, Eva, Sieper, Joachim, Bickham, Kara, Mehta, Anish, Frontera, Nancy, Stryszak, Paul, Popmihajlov, Zoran, Peloso, Paul M.
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2016
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5062857/
https://ncbi.nlm.nih.gov/pubmed/27737664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12891-016-1275-5
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы